Abstract
: Lepidium sativum seed (LS) is a plant used globally for its medicinal effect in treating diabetes. This study examined the ability of an aqueous extract of LS to treat diabetes and manage disorders of bodily functions. It used 70 male Wistar rats, each weighing between 190 g and 200 g. Diabetes was established in the rats by injecting them with Alloxan Solution at 150 mg/kg of body weight. The rats were considered diabetic if, after 24 hours, their blood glucose levels were higher than 180 mg/dl. Diabetes caused severe alterations in their blood serum glucose (376.608 mg/dl); their kidney functions (84.512 mg/dl for urea, 4.716 mg/dl for uric acid, and 0.376 mg/dl for creatinine); their liver functions (46.150 U/L for ALT, 45.654 U/L for AST, 5.431 U/L for albumin, and 7.611 U/L for globulin); and their lipid profile (79.123 mg/dl for triglycerides, 121.113 mg/dl for total cholesterol, 62.776 mg/dl for LDL, and 27.453 mg/dl for HDL). The findings suggest that it is beneficial to use LS to treat and manage disorders of bodily functions in rats.
Recommended Citation
El-Emary, Gehan
(2021)
"Role of Lepidium sativum in Treating Diabetes and Managing Bodily Functions’ Disorders in Rats.,"
Karbala International Journal of Modern Science: Vol. 7
:
Iss.
2
, Article 4.
Available at:
https://doi.org/10.33640/2405-609X.2773
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
